Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy-Reference-Cited by-同舟云学术

Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy

Published:2018-06-03 Issue:3 Volume:36 Page:584-590
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Lou Yinjun¹^ORCID,Lu Ying²,Zhu Zhijuan¹³,Ma Yafang¹,Suo Shanshan¹,Wang Yungui¹,Chen Dong²,Tong Hongyan¹,Qian Wenbin¹,Meng Haitao¹,Mai Wenyuan¹,Yu Wenjun¹,Xu Weilai¹,Wang Lei¹,Mao Liping¹,Pei Renzhi²,Jin Jie¹

Affiliation:

1. Department of Hematology, Leukemia center; The First Affiliated Hospital of Zhejiang University, College of Medicine; Key Laboratory of Hematopoietic Malignancies in Zhejiang Province; Hangzhou Zhejiang People's Republic of China

2. Department of Hematology; the Ningbo Yinzhou People's Hospital; Zhejiang People's Republic of China

3. Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology; Fujian Medical University Union Hospital; Fuzhou Fujian People's Republic of China

Funder

Medical and Health Science Project of Zhejiang Province

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2519/fullpdf

Reference31 articles.

1. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients;Shen;Blood,1997

2. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide;Soignet;N Engl J Med,1998

3. Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia;Raffoux;J Clin Oncol,2003